Cart (0 Items)
Your cart is currently empty.
View ProductsSize | |
---|---|
Brand | |
Product type | |
Clonality | |
Expression system | |
Applications |
Product name | Stable Isotope Labeled Adalimumab Biosimilar - Anti-TNF alpha mAb - Research Grade |
---|---|
Source | DrugBank DB00051 |
Species | Human |
Expression system | Mammalian cells |
Molecular weight | 144kDa |
Purity | >90% |
Buffer | PBS pH7.5 |
Delivery condition | Blue ice (+4°C) |
Storage condition | 4°C for short term; -20°C for long term |
Brand | ProteoGenix |
Applications | MS |
Aliases /Synonyms | Adalimumab |
Reference | PX-TA1001-SIL |
Related Products | PX-P4641 |
Note | For research use only. Not suitable for clinical or therapeutic use. |
Isotype | IgG1 |
Clonality | Monoclonal Antibody |
Format | Lyophilized |
Labelling | Arginine: 13C6,15N4 ; Lysine: 13C6,15N2 |
Isotopic Enrichment | 99% |
Stability | 1 year |
Formula | C6428H9912N1694O1987S46 |
Adalimumab is a recombinant, human IgG1 monoclonal antibody directed against tumor necrosis factor-alpha (TNF-alpha), with immunomodulating activity. Upon administration, adalimumab binds to TNF-alpha, thereby preventing its binding to the p55 and p75 TNF cell surface receptors and inhibiting TNF-mediated immune responses. TNF-alpha, a pro-inflammatory cytokine, is upregulated in various autoimmune diseases. Check for active clinical trials using this agent.
Related products
Reviews
Il n’y a pas encore d’avis.